News
Novartis’ Beovu recommended by NICE
Thousands of people could receive transformational treatment after a new option for diabetic macular oedema (DMO) was recommended by NICE.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Thousands of people could receive transformational treatment after a new option for diabetic macular oedema (DMO) was recommended by NICE.